Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olivier Gouin

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Microorganisms|June 26, 2026
An Ex Vivo '<i>Leaky Skin</i>' Model to Study Early Events Induced by <i>Staphylococcus aureus</i> ProteaseAndrea Cavagnino, Olivier Gouin, Lionel Breton, et al.
Current Opinion in Pharmacology|January 6, 2019
Current pharmaceutical developments in atopic dermatitisLaurent Misery, Flavien Huet, Olivier Gouin, et al.
The Journal of Investigative Dermatology|March 15, 2020
Transgenic Kallikrein 14 Mice Display Major Hair Shaft Defects Associated with Desmoglein 3 and 4 Degradation, Abnormal Epidermal Differentiation, and IL-36 SignatureOlivier Gouin, Claire Barbieux, Florent Leturcq, et al.
The Journal of Investigative Dermatology|December 3, 2023
Highly Efficient Ex Vivo Correction of COL7A1 through Ribonucleoprotein-Based CRISPR/Cas9 and Homology-Directed Repair to Treat Recessive Dystrophic Epidermolysis BullosaCamille Berthault, Sonia Gaucher, Olivier Gouin, et al.
Experimental Dermatology|July 17, 2015
Self-maintenance of neurogenic inflammation contributes to a vicious cycle in skinOlivier Gouin, Nicolas Lebonvallet, Killian L'Herondelle, et al.
Protein & Cell|April 2, 2017
TRPV1 and TRPA1 in cutaneous neurogenic and chronic inflammation: pro-inflammatory response induced by their activation and their sensitizationOlivier Gouin, Killian L'Herondelle, Nicolas Lebonvallet, et al.
Experimental Dermatology|December 28, 2017
A new tool to test active ingredient using lactic acid in vitro, a help to understand cellular mechanism involved in stinging test: An example using a bacterial polysaccharide (Fucogel<sup>®</sup> )Mehdi Sakka, Raphael Leschiera, Christelle Le Gall-Ianotto, et al.
British Journal of Pharmacology|August 31, 2021
Chronic itch: emerging treatments following new research conceptsLaurent Misery, Emilie Brenaut, Ophélie Pierre, et al.
The Journal of Allergy and Clinical Immunology|September 20, 2021
Netherton syndrome subtypes share IL-17/IL-36 signature with distinct IFN-α and allergic responsesClaire Barbieux, Mathilde Bonnet des Claustres, Matthias Fahrner, et al.
The Journal of Investigative Dermatology|February 20, 2018
Major Role for TRPV1 and InsP3R in PAR2-Elicited Inflammatory Mediator Production in Differentiated Human KeratinocytesOlivier Gouin, Killian L'Herondelle, Paul Buscaglia, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Microorganisms|June 26, 2026
An Ex Vivo '<i>Leaky Skin</i>' Model to Study Early Events Induced by <i>Staphylococcus aureus</i> ProteaseAndrea Cavagnino, Olivier Gouin, Lionel Breton, et al.
Current Opinion in Pharmacology|January 6, 2019
Current pharmaceutical developments in atopic dermatitisLaurent Misery, Flavien Huet, Olivier Gouin, et al.
The Journal of Investigative Dermatology|March 15, 2020
Transgenic Kallikrein 14 Mice Display Major Hair Shaft Defects Associated with Desmoglein 3 and 4 Degradation, Abnormal Epidermal Differentiation, and IL-36 SignatureOlivier Gouin, Claire Barbieux, Florent Leturcq, et al.
The Journal of Investigative Dermatology|December 3, 2023
Highly Efficient Ex Vivo Correction of COL7A1 through Ribonucleoprotein-Based CRISPR/Cas9 and Homology-Directed Repair to Treat Recessive Dystrophic Epidermolysis BullosaCamille Berthault, Sonia Gaucher, Olivier Gouin, et al.
Experimental Dermatology|July 17, 2015
Self-maintenance of neurogenic inflammation contributes to a vicious cycle in skinOlivier Gouin, Nicolas Lebonvallet, Killian L'Herondelle, et al.
Protein & Cell|April 2, 2017
TRPV1 and TRPA1 in cutaneous neurogenic and chronic inflammation: pro-inflammatory response induced by their activation and their sensitizationOlivier Gouin, Killian L'Herondelle, Nicolas Lebonvallet, et al.
Experimental Dermatology|December 28, 2017
A new tool to test active ingredient using lactic acid in vitro, a help to understand cellular mechanism involved in stinging test: An example using a bacterial polysaccharide (Fucogel<sup>®</sup> )Mehdi Sakka, Raphael Leschiera, Christelle Le Gall-Ianotto, et al.
British Journal of Pharmacology|August 31, 2021
Chronic itch: emerging treatments following new research conceptsLaurent Misery, Emilie Brenaut, Ophélie Pierre, et al.
The Journal of Allergy and Clinical Immunology|September 20, 2021
Netherton syndrome subtypes share IL-17/IL-36 signature with distinct IFN-α and allergic responsesClaire Barbieux, Mathilde Bonnet des Claustres, Matthias Fahrner, et al.
The Journal of Investigative Dermatology|February 20, 2018
Major Role for TRPV1 and InsP3R in PAR2-Elicited Inflammatory Mediator Production in Differentiated Human KeratinocytesOlivier Gouin, Killian L'Herondelle, Paul Buscaglia, et al.
Pageof 1